相关实验视频
Updated: Aug 11, 2026

08:39
Operant Sensation Seeking in the Mouse
Published on: November 10, 2010
13.0K
在雄性大鼠中,β2* nAChR敏感度调节了可卡因自我管理的获取
Noah B Walker1, Brenton R Tucker1, Leanne N Thomas1
1Department of Physiology & Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Neuropharmacology
|March 20, 2024
概括
改变大脑中的尼古丁乙胆受体 (nAChRs) 会加速可卡因自给的获取. 这表明,准胆固醇系统可以治疗可卡因使用障碍 (CUD).
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成研究 研究成研究
背景情况:
- 尼古丁乙胆受体 (nAChRs) 与可卡因的奖励作用有关.
- 胆固醇系统是调节可卡因使用障碍 (CUD) 的潜在治疗标.
研究的目的:
- 调查含β2亚单元的nAChRs在获得和维持可卡因自我管理中的特定作用.
- 为了确定增强nAChR敏感性是否会在不同的实验条件下影响可卡因强化.
主要方法:
- 用于基因改造的老鼠,在腹膜区域表达过敏的β2 nAChR亚单元 (β2Leu9'Ser).
- 用固定比率 (FR) 和渐进比率 (PR) 方案评估静脉可卡因自给.
- 食品自给也被评估在FR和PR表中作为对照.
主要成果:
- 与对照组相比,具有过敏β2 nAChRs的老鼠获得可卡因自给药的速度要快得多,并且在固定比例的时间表上更有可能获得可卡因.
- 在渐进式比率表上,在可卡因摄入量之间没有观察到显著差异.
- 控制和改造的老鼠在固定比例和渐进比例表中表现出类似的食物自我管理行为.
结论:
- 含有高亲和度,异种胺β2*的nAChRs在可卡因自我管理的获取阶段发挥着关键作用.
- 在获得可卡因自给药时,中层乙胆信号传递是活跃的.
- 胆固醇信号对可卡因增强的影响可能取决于特定的实验参数,例如增强时间表.
相关概念视频
G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Cholinergic Receptors: Muscarinic
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

